Indian Army Department of Military Affairs Medical Supplies Tender 2026 - Injectable Drugs, Ophthalmic Syrups & Misc. Pharmaceuticals

Tender Overview

The Indian Army, Department of Military Affairs, seeks supply of a broad range of medicinal products including Adrenaline 1ml injectables, Xylazine Hydrochloride 23.22 mg/ml in 10 ml vials, Diazepam 10 mg in 2 ml ampoules, haemocoagulase solution, Cefotaxime 1 g injections, Meloxicam 5 mg with Paracetamol 150 mg per 30 ml vial, Tribivet 30 ml, Iron Sucrose 5 ml injectables, Dizin syrup, Neeri syrup, Oxytetracycline spray, Calamine powder, Praziquantel 50 mg, Febantel 150 mg, Pyrantel Embonate 144 mg tablets. Estimated value and start/end dates are not disclosed in the data. The tender includes a 25% quantity option clause allowing upward or downward adjustments during contract performance, subject to contracted rates, with delivery timing anchored to the last delivery order date. The procurement appears to target a multi-line pharmaceutical stocking requirement for military medical usage. Unique aspects include varied dosage forms (injectables, syrups, powders, sprays, tablets) and a flexible delivery window aligned to expansion of orders. This requires robust compliance across GMP/pharmacopoeial standards and reliable cold-chain or storage practices as applicable.

Technical Specifications & Requirements

• Product categories span injectables, syrups, sprays, powders, and tablets (13 items total in BOQ).
• Specific dosage forms identified include:
  • Adrenaline 1ml injection
  • Xylazine Hydrochloride 23.22 mg/ml in 10 ml vial
  • Diazepam 10 mg in 2 ml ampoule
  • Haemocoagulase solution from Botrops venom
  • Cefotaxime 1 g injection
  • Meloxicam 5 mg with Paracetamol 150 mg per 30 ml vial
  • Tribivet 30 ml
  • Iron Sucrose 5 ml
  • Dizin syrup, Neeri syrup (200 ml-170 ml bottle ranges)
  • Oxytetracycline spray with Gentian Violet 0.7 g
  • Calamine powder 500 g
  • Praziquantel 50 mg, Febantel 150 mg, Pyrantel Embonate 144 mg tablets
• No explicit technical standards or certification codes are provided in the data; however, the breadth implies compliance with pharmacopoeial quality and stabilization for injectable/sterile products.
• BOQ indicates 13 items but no itemized quantities; bidders must infer scope and prepare for multi-line pricing and supply readiness across units. Date and location details are not specified, requiring bidders to confirm delivery cadence post-order.